The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery.
about
Brain tumorsMalignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methodsEmerging methods for disease monitoring in malignant gliomasCurrent molecular imaging of spinal tumors in clinical practice.Differentiation of local tumor recurrence from radiation-induced changes after stereotactic radiosurgery for treatment of brain metastasis: case report and review of the literature.Cerebral radiation necrosis.Imaging in neurooncologySwitching on the lights for real-time multimodality tumor neuroimaging: The integrated positron-emission tomography/MR imaging system.Molecular imaging of gliomas with PET: opportunities and limitations.Radiation necrosis following treatment of high grade glioma--a review of the literature and current understanding.Double trouble: a tale of two radio-treatments.Laser interstitial thermal therapy for focal cerebral radiation necrosis: a case report and literature review.Neuroimaging findings of the post-treatment effects of radiation and chemotherapy of malignant primary glial neoplasmsComparison of proton magnetic resonance spectroscopy with fluorine-18 2-fluoro-deoxyglucose positron emission tomography for assessment of brain tumor progression.Differentiating treatment-induced necrosis from recurrent/progressive brain tumor using nonmodel-based semiquantitative indices derived from dynamic contrast-enhanced T1-weighted MR perfusion.Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats.Intensity-Curvature Measurement Approaches for the Diagnosis of Magnetic Resonance Imaging Brain Tumors.Prognostic significance of parameters derived from co-registered 18F-fluorodeoxyglucose PET and contrast-enhanced MRI in patients with high-grade gliomaComparison between MR Perfusion and 18F-FDG PET in Differentiating Tumor Recurrence from Nonneoplastic Contrast-enhancing TissueSystemic treatment in breast cancer: a primer for radiologistsNCI-sponsored trial for the evaluation of safety and preliminary efficacy of 3'-deoxy-3'-[18F]fluorothymidine (FLT) as a marker of proliferation in patients with recurrent gliomas: preliminary efficacy studiesAdaptive hypofractionated gamma knife radiosurgery for a large brainstem metastasis.Magnetic resonance spectroscopic study of radiogenic changes after radiosurgery of cerebral arteriovenous malformations with implications for the differential diagnosis of radionecrosis.A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation.Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology.Comparison of the effectiveness of MRI perfusion and fluorine-18 FDG PET-CT for differentiating radiation injury from viable brain tumor: a preliminary retrospective analysis with pathologic correlation in all patientsRadiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrenceStereotactic radiosurgery (SRS) for brain metastases: a systematic review.Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.In Vivo DCE-MRI for the Discrimination Between Glioblastoma and Radiation Necrosis in Rats.Radiotherapy response evaluation using FDG PET-CT-established and emerging applications.Radiation injury vs. recurrent brain metastasis: combining textural feature radiomics analysis and standard parameters may increase 18F-FET PET accuracy without dynamic scans.Conversion of arterial input functions for dual pharmacokinetic modeling using Gd-DTPA/MRI and 18F-FDG/PET.A comparison study of (11)C-methionine and (18)F-fluorodeoxyglucose positron emission tomography-computed tomography scans in evaluation of patients with recurrent brain tumors.Role of FDG-PET/MRI, FDG-PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas.Incidence and clinical course of radionecrosis in children with brain tumors. A 20-year longitudinal observational study.Precision radiotherapy for brain tumors: A 10-year bibliometric analysis.Diapeutic cancer-targeting alkylphosphocholine analogs may advance management of brain malignancies.The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade IIDiagnostic Accuracy of PET, SPECT, and Arterial Spin-Labeling in Differentiating Tumor Recurrence from Necrosis in Cerebral Metastasis after Stereotactic Radiosurgery.
P2860
Q24605136-3AF962B3-8E98-4A46-860F-8D26E5A5D950Q26853516-7F6DC807-99CB-4D45-BDD4-A39D83084184Q27023823-3C2FF73A-FCC0-42CE-A228-8856F6B8CEAAQ30476277-478217A0-A3A1-4695-8360-E8F31629DDF7Q30599841-0677397F-2CF8-47A3-BF54-DBC8D7A45824Q30686634-C67D2EE9-C50A-4D62-9093-7CCAF1C6875AQ30989939-89FD57F4-AC3F-4807-A311-BAB85A821E95Q33516753-216912CC-3A63-4FE4-8B93-C66A4ED80579Q33961188-7471DAA9-3BC6-4C90-A98D-28E25DA6A572Q34087196-2BFC3394-61E9-4C10-8D0B-53481F2035F5Q34220119-FF892A32-35F2-4515-9299-0496518499E9Q34296854-2F84E4EC-340E-413B-AD53-C3B96CCF0AD3Q34369465-CA91FE52-BBC2-4BB8-AA31-423B1C1C6381Q35103504-62FA9486-36D5-4FB7-8EFF-404DF3D97A4FQ35170356-D9147CAE-36A3-4AD0-9B0B-C81ACB63EEEAQ36112565-051F4E67-1C79-449D-8AE5-C808CB66DB98Q36272371-20FF626A-9E29-41CA-A33D-5738B481FF74Q36324020-7F6C70E3-831E-4547-AC1F-4A46518FB02DQ36356127-FAC79D20-6F47-493F-A73B-4714068C5012Q36510679-64FB3E99-EB5F-4127-89CC-AA12FF7C31CCQ36539340-21708BD5-E8DD-4E40-B513-7661F001F28DQ36612068-1BFB5C53-49DB-4014-B5EA-EB2802F3FBD8Q36753743-E1FC829A-9774-472A-8FAA-2916871CD3A9Q36893250-97A9A6D2-5641-4A92-AFDB-8151E6D0E494Q36926781-F5245A2F-E669-41FC-B5FF-C1B258979C89Q37212449-DAA5CAAD-BB8F-42D7-8242-3FFA55E86CA0Q37233933-32504977-594E-4DD7-83FC-1C2CD4B725FFQ38228670-F374AED3-0F97-4D5C-A2C4-D5885480CF37Q38815396-E00DC41C-37B9-47B3-94F7-BE49FB51860DQ38902139-73A58DD0-7B2E-405A-8A71-588BCE3C0EFDQ39051286-C3B6EEB7-0576-483D-880D-D3F24E827EE1Q39181712-9EA47049-DF18-42C9-B596-A0FC423E7706Q39351705-315B031B-FC82-4BB4-B501-83C9DB2A4EA5Q39724277-E6674961-DD32-4305-8A63-DF5A2102F7ACQ40118689-0B0C5E6D-277B-445C-BE9E-4D9F568A6276Q40132151-DF50DB8A-33F6-4973-9664-6425C811F6B0Q41521476-99B8F889-EB24-40C7-8FA4-7EFC0E9667F8Q41638130-30C51C51-7E01-41FF-BC44-58CB404255E1Q42734117-2AF1DA40-D4C5-4863-97EF-C3E35B635363Q43946394-AACC739D-924C-4482-9EDB-1307E4E8984A
P2860
The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
The sensitivity and specificit ...... ith stereotactic radiosurgery.
@en
The sensitivity and specificit ...... ith stereotactic radiosurgery.
@nl
type
label
The sensitivity and specificit ...... ith stereotactic radiosurgery.
@en
The sensitivity and specificit ...... ith stereotactic radiosurgery.
@nl
prefLabel
The sensitivity and specificit ...... ith stereotactic radiosurgery.
@en
The sensitivity and specificit ...... ith stereotactic radiosurgery.
@nl
P2093
P2860
P356
P1476
The sensitivity and specificit ...... ith stereotactic radiosurgery.
@en
P2093
P2860
P304
P356
10.1002/IJC.1016
P577
2001-06-01T00:00:00Z